A Harvard Business School Healthcare Alumni Association Q&A with Paul Ollinger, one of Facebook’s first 250 employees.

The survey shows voters, regardless of party affiliation, still support vaccines and are concerned about the reduction in ...

Direct-to-consumer advertising can be a controversial topic in the pharma industry. While the US isn’t the only other country ...

The two organizations will provide multi-modal learning experiences, opportunities to work with peers, and more.

Q4 earnings for companies such as Johnson & Johnson, Teva, and Roche highlight the impact of significant innovations brought ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...

Many companies and investors believe that AI has to potential to reshape various elements of the pharma industry. Two ...

The new app provides user with more features, including an AI-powered search, than the pharmacy’s previous app.

Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of ...